Displaying drugs 14626 - 14650 of 14815 in total
Mitazalimab
Mitazalimab is under investigation in clinical trial NCT02379741 (ADC-1013 First-in-Human Study).
Investigational
Matched Description: … Mitazalimab is under investigation in clinical trial NCT02379741 (ADC-1013 First-in-Human Study). …
Vopratelimab
Vopratelimab is under investigation in clinical trial NCT02904226 (JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors).
Investigational
Matched Description: … With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors). ... Vopratelimab is under investigation in clinical trial NCT02904226 (JTX-2011 Alone and in Combination …
WVE-003
WVE-003 is an allele-selective antisense oligonucleotide that works to selectively reduce the toxic mutant huntingtin (mHTT) protein.
Investigational
Matched Description: … WVE-003 is an allele-selective antisense oligonucleotide that works to selectively reduce the toxic mutant …
Modipafant
Modipafant is under investigation in clinical trial NCT02569827 (Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore).
Investigational
Matched Iupac: … ethyl (4R)-4-(2-chlorophenyl)-6-methyl-2-(4-{2-methyl-1H-imidazo[4,5-c]pyridin-1-yl}phenyl)-5-[(pyridin …
Matched Description: … for Adult Participants With Uncomplicated Dengue Fever in Singapore). ... Modipafant is under investigation in clinical trial NCT02569827 (Celgosivir or Modipafant as Treatment …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Description: … for Adult Participants With Uncomplicated Dengue Fever in Singapore). ... Modipafant is under investigation in clinical trial NCT02569827 (Celgosivir or Modipafant as Treatment …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Sodelglitazar
Sodelglitazar is under investigation in clinical trial NCT00196989 (Study in People With Type 2 Diabetes).
Investigational
Matched Description: … Sodelglitazar is under investigation in clinical trial NCT00196989 (Study in People With Type 2 Diabetes …
Budiodarone
Budiodarone (ATI-2042) is an antiarrhythmic related to amiodarone that is currently being studied in clinical trials.
Investigational
Matched Iupac: … (2S)-butan-2-yl 2-(3-{4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl}-1-benzofuran-2-yl)acetate …
Matched Description: … Budiodarone (ATI-2042) is an antiarrhythmic related to amiodarone that is currently being studied in …
Matched Description: … Budiodarone (ATI-2042) is an antiarrhythmic related to amiodarone that is currently being studied in …
Dotarizine
Investigational
Matched Iupac: … 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl)propyl]piperazine …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Gavilimomab
Investigational
Fispemifene
Investigational
Matched Iupac: … 2-(2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}ethoxy)ethan-1-ol …
Dextofisopam
Investigational
Matched Iupac: … (5R)-1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine …
Lanifibranor
Lanifibranor is under investigation in clinical trial NCT03008070 (Phase 2b Study in NASH to Assess IVA337).
Investigational
Matched Iupac: … 4-[1-(1,3-benzothiazole-6-sulfonyl)-5-chloro-1H-indol-2-yl]butanoic acid …
Matched Description: … Lanifibranor is under investigation in clinical trial NCT03008070 (Phase 2b Study in NASH to Assess IVA337 …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Description: … Lanifibranor is under investigation in clinical trial NCT03008070 (Phase 2b Study in NASH to Assess IVA337 …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Lacnotuzumab
Lacnotuzumab is under investigation in clinical trial NCT01643850 (MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS)).
Investigational
Matched Description: … Lacnotuzumab is under investigation in clinical trial NCT01643850 (MCS110 in Patients With Pigmented …
Hydroquinidine
Hydroquinidine is under investigation in clinical trial NCT00927732 (Hydroquinidine Versus Placebo in Patients With Brugada Syndrome).
Investigational
Matched Iupac: … (S)-[(1S,2R,4S,5R)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol …
Matched Description: … Hydroquinidine is under investigation in clinical trial NCT00927732 (Hydroquinidine Versus Placebo in …
Matched Description: … Hydroquinidine is under investigation in clinical trial NCT00927732 (Hydroquinidine Versus Placebo in …
Pidilizumab
Pidilizumab is under investigation in clinical trial NCT01952769 (Anti PD1 Antibody in Diffuse Intrinsic Pontine Glioma).
Investigational
Matched Description: … Pidilizumab is under investigation in clinical trial NCT01952769 (Anti PD1 Antibody in Diffuse Intrinsic …
CM-4307
CM-4307 is under investigation in clinical trial NCT03602495 (Donafenib in 131I-Refractory Differentiated Thyroid Cancer).
Investigational
Matched Description: … CM-4307 is under investigation in clinical trial NCT03602495 (Donafenib in 131I-Refractory Differentiated …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
TRU-015
Investigational
PRX-03140
Investigational
Matched Iupac: … 4-hydroxy-6-oxo-N-[3-(piperidin-1-yl)propyl]-7-(propan-2-yl)-6H,7H-thieno[2,3-b]pyridine-5-carboxamide …
Tarazepide
Investigational
Matched Iupac: … N-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-1-azatricyclo[6.3.1.0^{4,12}]dodeca …
Labradimil
Investigational
Matched Iupac: … (2S)-2-{[(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-(2-{[(2S,4R)-1-[(2S)-1-[(2S)-2-amino-5-[(diaminomethylidene) …
Naratuximab emtansine
Naratuximab emtansine is under investigation in clinical trial NCT01534715 (IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia).
Investigational
Matched Description: … Naratuximab emtansine is under investigation in clinical trial NCT01534715 (IMGN529 in Treating Patients …
Menaquinone
Menaquinone is under investigation in clinical trial NCT01533441 (Vitamin K2 Intervention in Patients With Vitamin K Antagonists).
Investigational
Matched Iupac: … 2-methyl-3-[(2E,6E,10E,14E)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaen-1-yl]-1,4-dihydronaphthalene …
Matched Description: … Menaquinone is under investigation in clinical trial NCT01533441 (Vitamin K2 Intervention in Patients …
Matched Description: … Menaquinone is under investigation in clinical trial NCT01533441 (Vitamin K2 Intervention in Patients …
Simotaxel
Simotaxel is under investigation in clinical trial NCT00088647 (Study Evaluating MST-997 in Advanced Malignant Solid Tumors).
Investigational
Matched Description: … Simotaxel is under investigation in clinical trial NCT00088647 (Study Evaluating MST-997 in Advanced …
Norleucine
Norleucine is under investigation in clinical trial NCT00081952 (Amino Acid Therapy for Hot Flashes in Postmenopausal Women).
Investigational
Matched Description: … Norleucine is under investigation in clinical trial NCT00081952 (Amino Acid Therapy for Hot Flashes in …
PEN-866
PEN-866 is under investigation in clinical trial NCT03221400 (PEN-866 in Patients With Advanced Solid Malignancies).
Investigational
Matched Iupac: … yl)ethyl]piperidine-1-carboxylate ... diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1( ... 4-[2-(5-{3-[2,4-dihydroxy-5-(propan-2-yl)phenyl]-5-oxo-4,5-dihydro-1H-1,2,4-triazol-4-yl}-1H-indol-1- …
Matched Description: … PEN-866 is under investigation in clinical trial NCT03221400 (PEN-866 in Patients With Advanced Solid …
Matched Description: … PEN-866 is under investigation in clinical trial NCT03221400 (PEN-866 in Patients With Advanced Solid …
Diflomotecan
Diflomotecan is under investigation in clinical trial NCT00080015 (Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC)).
Investigational
Matched Iupac: … -ethyl-6,7-difluoro-20-hydroxy-17-oxa-3,13-diazapentacyclo[11.9.0.0^{2,11}.0^{4,9}.0^{15,21}]docosa-1( …
Matched Description: … Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC)). ... Diflomotecan is under investigation in clinical trial NCT00080015 (Diflomotecan (BN80915) Administered …
Matched Description: … Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC)). ... Diflomotecan is under investigation in clinical trial NCT00080015 (Diflomotecan (BN80915) Administered …
Displaying drugs 14626 - 14650 of 14815 in total